<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34967726</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>08</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>15</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2385-2070</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>20</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>Blood transfusion = Trasfusione del sangue</Title>
          <ISOAbbreviation>Blood Transfus</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Evans syndrome in the SARS-CoV-2 era: "springing up like mushrooms".</ArticleTitle>
        <Pagination>
          <StartPage>89</StartPage>
          <EndPage>93</EndPage>
          <MedlinePgn>89-93</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.2450/2021.0224-21</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Fattizzo</LastName>
            <ForeName>Bruno</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Haematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016421">Editorial</PublicationType>
          <PublicationType UI="D016420">Comment</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>01</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Blood Transfus</MedlineTA>
        <NlmUniqueID>101237479</NlmUniqueID>
        <ISSNLinking>1723-2007</ISSNLinking>
      </MedlineJournalInfo>
      <SupplMeshList>
        <SupplMeshName Type="Disease" UI="C536380">Evans Syndrome</SupplMeshName>
      </SupplMeshList>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentOn">
          <RefSource>Blood Transfus. 2022 Mar;20(2):168-172</RefSource>
          <PMID Version="1">34369874</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000363" MajorTopicYN="Y">Agaricales</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000744" MajorTopicYN="Y">Anemia, Hemolytic, Autoimmune</DescriptorName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013921" MajorTopicYN="N">Thrombocytopenia</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>
<b>CONFLICT OF INTEREST STATEMENT</b>
. BF has no conflicts of interest related to the present manuscript to disclose. BF received consultancy honoraria from Annexon, Apellis, Alexion, Momenta, Novartis and Amgen.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>31</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>9</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>30</Day>
          <Hour>12</Hour>
          <Minute>19</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34967726</ArticleId>
        <ArticleId IdType="pmc">PMC8971015</ArticleId>
        <ArticleId IdType="doi">10.2450/2021.0224-21</ArticleId>
        <ArticleId IdType="pii">2021.0224-21</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Osti N, Ceolan J, Piccoli P, et al.  Acute haemolysis by cold antibody during SARS-CoV-2 infection in a patient with Evans syndrome: a case report and literature review. Blood Transfus. 2022;20:168–172.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8971017</ArticleId>
            <ArticleId IdType="pubmed">34369874</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barcellini W, Giannotta JA, Fattizzo B. Are patients with autoimmune cytopenias at higher risk of COVID-19 pneumonia? The experience of a Reference Center in Northern Italy and review of the literature. Front Immunol. 2021;11:609198.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7870679</ArticleId>
            <ArticleId IdType="pubmed">33574816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haberman R, Axelrad J, Chen A, et al.  Covid-19 in immune-mediated inflammatory diseases. Case series from New York. N Engl J Med. 2020;383:85–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7204427</ArticleId>
            <ArticleId IdType="pubmed">32348641</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taherifard E, Taherifard E, Movahed H, Mousavi MR. Hematologic autoimmune disorders in the course of COVID-19: a systematic review of reported cases. Hematology. 2021;26:225–39.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33594951</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fattizzo B, Michel M, Giannotta JA, et al.  Evans syndrome in adults: an observational multicentre study. Blood Adv. 2021;5:5468–5478.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8714709</ArticleId>
            <ArticleId IdType="pubmed">34592758</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hausmann JS, Kennedy K, Simard JF, et al.  COVID-19 Global Rheumatology Alliance. Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases. Lancet Rheumatol. 2021;3:e707–14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8298011</ArticleId>
            <ArticleId IdType="pubmed">34316727</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Angileri F, Légaré S, Marino Gammazza A, et al.  Is molecular mimicry the culprit in the autoimmune haemolytic anaemia affecting patients with COVID-19? Br J Haematol. 2020;190:e92–3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7283741</ArticleId>
            <ArticleId IdType="pubmed">32453861</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chauhan AJ, Wiffen LJ, Brown TP. COVID-19: a collision of complement, coagulation and inflammatory pathways. J Thromb Haemost. 2020;18:2110–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7361520</ArticleId>
            <ArticleId IdType="pubmed">32608159</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kubánková M, Hohberger B, Hoffmanns J, et al.  Physical phenotype of blood cells is altered in COVID-19. bioRxiv. 2021;120:2838–47.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8169220</ArticleId>
            <ArticleId IdType="pubmed">34087216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bastard P, Rosen LB, Zhang Q, et al.  Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370:eabd4585.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7857397</ArticleId>
            <ArticleId IdType="pubmed">32972996</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barcellini W, Fattizzo B. How I treat warm autoimmune hemolytic anemia. Blood. 2021;137:1283–94.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33512406</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barcellini W, Fattizzo B, Zaninoni A, et al.  Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients. Blood. 2014;124:2930–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25232059</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jacobs J, Eichbaum Q. COVID-19 associated with severe autoimmune hemolytic anemia. Transfusion. 2021;61:635–40.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7753740</ArticleId>
            <ArticleId IdType="pubmed">33274459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Avouac J, Drumez E, Hachulla E, et al.  COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study. Lancet Rheumatol. 2021;3:e419–e426.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7993930</ArticleId>
            <ArticleId IdType="pubmed">33786454</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fattizzo B. Evans syndrome and infections: a dangerous cocktail to manage with caution. Blood Transfus. 2021;19:5–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7850928</ArticleId>
            <ArticleId IdType="pubmed">33523800</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Focosi D, Franchini M, Pirofski LA, et al.  COVID-19 convalescent plasma is more than neutralizing antibodies: a narrative review of potential beneficial and detrimental co-factors. Viruses. 2021;13:1594.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8402718</ArticleId>
            <ArticleId IdType="pubmed">34452459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ehmsen S, Asmussen A, Jeppesen SS, et al.  Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer. Cancer Cell. 2021;39:1034–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8313483</ArticleId>
            <ArticleId IdType="pubmed">34348121</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murdych TM. A case of severe autoimmune hemolytic anemia after a receipt of a first dose of SARS-CoV-2 vaccine. Int J Lab Hematol. 2022;44:e10–e12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8444646</ArticleId>
            <ArticleId IdType="pubmed">34258873</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brito S, Ferreira N, Mateus S, et al.  A case of autoimmune hemolytic anemia following COVID-19 messenger ribonucleic acid vaccination. Cureus. 2021;13:e15035.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8200779</ArticleId>
            <ArticleId IdType="pubmed">34150386</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pérez-Lamas L, Moreno-Jiménez G, Tenorio-Núñez MC, et al.  Hemolytic crisis due to Covid-19 vaccination in a woman with cold agglutinin disease. Am J Hematol. 2021;96:e288–91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8212117</ArticleId>
            <ArticleId IdType="pubmed">33939851</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fattizzo B, Giannotta JA, Cecchi N, Barcellini W. SARS-CoV-2 vaccination in patients with autoimmune cytopenias: the experience of a reference center. Am J Hematol. 2021;96:e413–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8646755</ArticleId>
            <ArticleId IdType="pubmed">34478178</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Simpson CR, Shi T, Vasileiou E, et al.  First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland. Nat Med. 2021;27:1290–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8282499</ArticleId>
            <ArticleId IdType="pubmed">34108714</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Welsh KJ, Baumblatt J, Chege W, et al.  Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS) Vaccine. 2021;39:3329–32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8086806</ArticleId>
            <ArticleId IdType="pubmed">34006408</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
